BRIEF published on 02/22/2024 at 15:08, 7 months 10 days ago The Vanguard Group, Inc. reveals its position in Redrow plc The Vanguard Group Financial Market Redrow Plc Share Ownership Construction Sector
PRESS RELEASE published on 02/22/2024 at 15:08, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Redrow plc The Vanguard Group, Inc. discloses a 4.06% interest in Redrow plc through ownership of 13,420,834 ordinary shares. Additional disclosures include a sale of 12,816 shares at 6.70 GBP per unit The Vanguard Group Inc. Ownership Disclosure Financial Disclosure Redrow Plc Stock Sale
BRIEF published on 02/22/2024 at 15:05, 7 months 10 days ago Significant Participation of Vanguard Group in LondonMetric Property plc LondonMetric Property Plc Takeover Code Vanguard Group Real Estate Sector Investment Participation
PRESS RELEASE published on 02/22/2024 at 15:05, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.20% interest in LondonMetric Property plc. Details of the ownership revealed in Form 8.3 filing LondonMetric Property Plc Form 8.3 The Vanguard Group Inc. Ownership Disclosure Financial Securities
BRIEF published on 02/22/2024 at 15:04, 7 months 10 days ago The Vanguard Group, Inc. increases its stake in UK Commercial Property REIT Limited Real Estate Investment The Vanguard Group, Inc. UK Commercial Property REIT Limited Share/Stock British Financial Market
PRESS RELEASE published on 02/22/2024 at 15:04, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Limited The Vanguard Group, Inc. discloses positions in UK Commercial Property REIT Limited exceeding 1%. Dealings include the purchase and sale of 25p ordinary securities Form 8.3 The Vanguard Group Inc. Dealings UK Commercial Property REIT Limited Positions Disclosure
BRIEF published on 02/22/2024 at 15:02, 7 months 10 days ago The Vanguard Group, Inc. Increases Stake in Smith (DS) plc The Vanguard Group, Inc. Form 8.3 Investment Stock Market Smith (DS) Plc
PRESS RELEASE published on 02/22/2024 at 15:02, 7 months 10 days ago Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc The Vanguard Group, Inc. discloses a 4.50% stake in Smith (DS) plc. Details in Form 8.3 include 61,984,990 ordinary shares purchased at 53.20 GBP per share The Vanguard Group, Inc. Form 8.3 Share Purchase Stake Disclosure Smith (DS) Plc
BRIEF published on 02/21/2024 at 15:52, 7 months 11 days ago The Vanguard Group, Inc. announces its position on Mondi plc The Vanguard Group, Inc. Investment Takeover Code Mondi Plc Paper And Packaging Sector
PRESS RELEASE published on 02/21/2024 at 15:52, 7 months 11 days ago Form 8.3 - The Vanguard Group, Inc.: Mondi plc Form 8.3 disclosure by The Vanguard Group, Inc. regarding interests in Mondi plc securities representing 4.82% ownership. Details of positions and dealings included Securities The Vanguard Group, Inc. Form 8.3 Disclosure Mondi Plc
Published on 10/04/2024 at 01:00, 4 hours 23 minutes ago MedMira Announces the appointment of Vice President of Commercial Operations
Published on 10/03/2024 at 23:00, 6 hours 23 minutes ago 1933 Industries to Trade on the Pink Open Market
Published on 10/03/2024 at 23:00, 6 hours 23 minutes ago CMG Home Loans Announces the Opening of New Tampa Branch
Published on 10/03/2024 at 22:45, 6 hours 38 minutes ago Rektron Schedules Annual General and Special Meeting of Shareholders in Response to Shareholder Requisition
Published on 10/03/2024 at 22:30, 6 hours 53 minutes ago Line5 Earns Top Honors for Fourth Consecutive Year at the 2024 Dealers' Choice Awards
Published on 10/03/2024 at 22:01, 7 hours 21 minutes ago Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Published on 10/03/2024 at 22:01, 7 hours 22 minutes ago Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
Published on 10/03/2024 at 21:57, 7 hours 25 minutes ago EQS-Adhoc: Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Published on 10/03/2024 at 18:45, 10 hours 37 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/03/2024 at 17:45, 11 hours 38 minutes ago Aéroports de Paris SA - Voting rights as of 30 September 2024
Published on 10/03/2024 at 17:45, 11 hours 38 minutes ago CHARGEURS - Voting rights monthly statement as of September 30th, 2024
Published on 10/03/2024 at 17:42, 11 hours 40 minutes ago Mersen: Number of shares and voting rights as of September 30, 2024
Published on 10/03/2024 at 08:00, 21 hours 22 minutes ago KURMA PARTNERS ACHIEVES FIRST CLOSE OF NEW EUR 250 MILLION BIOFUND IV
Published on 10/02/2024 at 18:50, 1 day 10 hours ago AXA: Elimination of the dilutive impact of Shareplan 2024